The new COVID-19 subvariant BA.3.2, known as the 'Cicada' variant, has emerged as a significant health concern, particularly for children. This variant has been reported in 23 countries and detected in wastewater across 25 US states, raising alarms due to its 70-75 mutations that allow it to evade existing vaccine-induced immunity. First identified in South Africa on November 22, 2024, the variant poses a risk to children, who are infected at a rate five times higher than adults due to their less developed immune systems. Current data indicates that only 33 million children aged 12-14 in India have received their first vaccine dose, with a mere 14 million having received a booster, highlighting a significant gap in immunity among this vulnerable population.

Symptoms associated with the Cicada variant mirror those of previous COVID-19 infections, including cough, sore throat, and shortness of breath. Parents are advised to remain vigilant and seek medical attention if symptoms persist, especially after travel. To protect children, it is essential to implement preventive measures such as masking in crowded spaces, maintaining hand hygiene, and ensuring vaccination updates are prioritized. The World Health Organization and health authorities are monitoring the situation closely, emphasizing the importance of community-level strategies to safeguard children's health.